Abstract. Serum somatomedin B levels were determined by radioimmunoassay in 209 healthy boys and girls from one month to 16 years of age.
mg/l in boys. In older children the values increased to levels between 13 and 22 mg/l in boys and between 13 and 18.5 mg/l in girls. They were independent of the stage of pubertal development.
Somatomedin B levels were normal in 71 children with constitutional growth delay, primordial dwarfism, familial dwarfism and other forms of growth disturbance. The mean levels were between 12.1 and 14.4 mg/l. Values below 6 mg/l were present only in children with hGH deficiency. In these patients we could find an increase of the mean level from 4.3 mg/l without therapy to 9.4 mg/l under treatment.
Thus the determination of somatomedin B seems to be useful for the diagnosis of hGH deficiency.
Somatomedin B is a hGH dependent acid peptide with a molecular weight of 5000 Dalton. It is a unique protein with four disulfide cross-links and N-terminal aspartic acid. The primary structure has been determined and shows a close relationship to small trypsin inhibitors and phospholipases (Fryklund & Sievertsson 1978) . It is characterized by its property to stimulate DNA synthesis in human glia-like cells by increasing thymidine up¬ take (Uthne 1973 Underwood & van Wyk 1979) .
In 1975 a radioimmunoassay for somatomedin B was developed by Yalow et al. (1975) . Before that somatomedin was determined by bioassay or radioreceptorassay (Takano 1975 ; Van (Evermann et al. 1977; Yalow et al. 1975) and depressed in patients with hGH deficiency compared to normal levels (Evermann et al. 1979; Hizuka et al. 1978; Yalow et al. 1975 Except in children with hGH deficiency the levels were normal (Fig. 4) (Hall 1972; Hizuka et al. 1978 ). (Broughton & Jones 1981) , to be a reliable screen¬ ing method for hGH deficiency. It seems to be justified to perform more inconvenient hGH sti¬ mulation methods only in patients with somato¬ medin B levels below 6 mg/1.
